Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital

Journal of Hospital Infection

Volumn 68, Issue 1, 2008, Pages 17-24

  Libert, M ^a   Elkholti, M ^a   Massaut, J ^a   Karmali, R ^a   Mascart, G ^a   Cherifi, S ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Mortality; Risk factors for meticillin resistance; Staphylococcus aureus bloodstream infection

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; INSULIN; METICILLIN; POLYPEPTIDE ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; COMMUNICABLE DISEASE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; DRUG EXPOSURE; ENDOCARDITIS; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; RISK ASSESSMENT; RISK FACTOR; SEPTIC SHOCK; STAPHYLOCOCCUS INFECTION; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BELGIUM; CARRIER STATE; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HOMES FOR THE AGED; HOSPITALS, UNIVERSITY; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; NURSING HOMES; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 37749043517     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2007.08.021     Document Type: Article

References (31)

1. National Nosocomial Infections Surveillance (NNIS). System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 27 (1999) 520-532
2. European Antimicrobial Resistance Surveillance System: annual report 2004. p. 50-53.
3. Kopp B.J., Nix D.E., and Armstrong E.P. Clinical and economic analysis of methicillin-susceptible and -resistant S. aureus infections. Ann Pharmacother 38 (2004) 1377-1382
4. Cosgrove S., Sakoulas G., Perencevich E., Schwaber M.J., Karchmer A.W., and Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36 (2003) 53-59
5. Lodise Jr. T.P., McKinnon P.S., and Rybak M. Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance. Infect Control Hosp Epidemiol 24 (2003) 655-661
6. McHugh C.G., and Riley Lee W. Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections. Infect Control Hosp Epidemiol 25 (2004) 425-430
7. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC Definitions of nosocomial infections. In: Olmsted R.N. (Ed). Infection Control and Applied Epidemiology: Principles and Practice (1996), Mosby, St Louis A-1-A-20
8. McCabe W., and Jackson G. Gram-negative bacteremia: I. Etiology and ecology. Arch Intern Med 110 (1962) 847-855
9. Das I., O'Connell N., and Lambert P. Epidemiology, clinical and laboratory characteristics of Staphylococcus aureus bacteraemia in a university hospital in UK. J Hosp Infect 65 (2007) 117-123
10. Maki D.G., Weise C.E., and Sarafoin H.W. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296 (1977) 1305-1309
11. Sekeres M.A., Abrutyn E., Berlin J.A., et al. An assessment of the usefulness of the Duke criteria for diagnosing active infective endocarditis. Clin Infect Dis 24 (1997) 1185-1190
12. Bannermann T.L. Staphylococcus, micrococcus, and other catalase-positive cocci that grow aerobically. In: Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.H. (Eds). Manual of Clinical Microbiology (2003), American Society for Microbiology, Washington, DC 384-404
13. Nosocomial bacteraemia surveillance in Belgian hospitals, National Surveillance System, 1992-2001.
14. National surveillance of nosocomial infections in Belgian hospitals (NSIH). Public Health Institute, annual report 2005. p. 1-10.
15. Roghmann M.C. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 160 (2000) 1001-1004
16. Denis O., Deplano A., Nonhoff C., et al. National surveillance of methicillin-resistant Staphylococcus aureus in Belgian hospitals indicates rapid diversification of epidemics clones. Antimicrob Agents Chemother 48 (2004) 3625-3629
17. Jernigan J., Pullen A., Flowers L., Bell M., and Jarvis W. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission. Infect Control Hosp Epidemiol 24 (2003) 409-414
18. Denis O., Suetens C., Struelens M., and Jans B. Preliminary results of the national surveillance of methicillin resistant Staphylococcus aureus (MRSA) epidemiology in nursing homes in Belgium in 2005. Noso-info 9 (2005) 9-10
19. Pujol M., Pena C., Pallares R., Ayats J., Ariza J., and Gudiol F. Risk factors for nosocomial bacteraemia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 13 (1994) 96-102
20. Guilarde A., Turchi M., Martelli C., and Primo M. Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital. Infect Control Hosp Epidemiol 63 (2006) 330-336
21. Boyko E.J., Ahroni J.H., Stensel V., Forsberg R.C., Davignon D.R., and Smith D.G. A prospective study of risk factors for diabetic foot ulcer. Diabetes Care 22 (1999) 1036-1042
22. Dang C.N., Prasad Y.D., Boulton A.J., and Jude E.B. Meticillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 20 (2003) 159-161
23. Conterno L.O., Wey S.B., and Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 19 (1998) 32-37
24. Romero-Vivas J., Rubio M., Fernandez C., and Picazo J. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 21 (1995) 1417-1423
25. Cosgrove S., Youlin Q., Kaye K., Harbarth S., Karchmer A., and Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26 (2005) 166-174
26. Melzer M., Eykyn S.J., Gransden W.R., and Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 37 (2003) 1453-1460
27. Harbarth S., Rutschmann O., Sudre P., and Pittlet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 158 (1998) 182-189
28. Willcox P.A., Rayner B.L., and Whitelaw D.A. Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs. Q J Med 91 (1998) 41-47
29. Steinberg J.P., Clark C.C., and Hackman B.O. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 23 (1996) 255-259
30. Chang F.Y., McDonald B.B., Peacock J.E., et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine 82 (2003) 322-332
31. Pan A., Carnevale G., Catenazzi P., et al. Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA. Infect Control Hosp Epidemiol 26 (2005) 127-133